Evidence in BRAF-Mutant CRC Tumors

BRAF-mutated CRC: testing to treatmentПодробнее

BRAF-Mutated mCRC: From Diagnosis to TreatmentПодробнее

Colon, Rectal, and Anal Cancer | 2023 Best of GI Cancer ConferenceПодробнее

Cancer Dependency Mapping to Guide Drug DiscoveryПодробнее

Dr. Kopetz on Updated Data From BEACON CRC Study in BRAF V600E–Mutant CRCПодробнее

Dr. Kopetz on Safety Data From BEACON CRC Trial in BRAF V600E-Mutant mCRCПодробнее

Addressing BRAF Mutations in Colon Cancer: New Data from ASCO 2017Подробнее

BREAKWATER: encorafenib plus cetuximab in patients with BRAF V600E-mutant mCRCПодробнее

Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalkПодробнее

New Advances in Treatments for Colorectal CancerПодробнее

Initial Management of Metastatic CRC in 2019Подробнее

Case 1: Treatment of BRAF-Mutated Colorectal CancerПодробнее

Scott Kopetz, MD, shares updates from the BEACON trial in BRAF-mutant colorectal cancerПодробнее

Case 1: BRAF-Mutated Metastatic Colorectal CancerПодробнее

How BRAF V600E-Mutated CRC is Treated Differently Than Other CancersПодробнее

How to approach the patient with a BRAF mutant tumorПодробнее

How to Approach the Patient With BRAF Mutant TumorПодробнее

Novel Agents and Targets in Colorectal CancerПодробнее

Triplet Regimen Improves Responses in BRAF V600E+ Metastatic CRCПодробнее

Safety Lead-In Data for BEACON CRC Trial With Triplet Biologic Regimen in mCRCПодробнее